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1. Introduction:
Validation of the analytical procedure is an integral part of 
drug formulation development process. It ensures that the 
developed analytical method can be employed for detecting 
the amount of analyte in the sample and also the impurities 
if any. Validation of the UV-Visible Spectrophotometric 
method for a given drug can be achieved by determining the 
analytical characteristics- Linearity, Robustness, Precision, 
Accuracy, Limit of Detection and Quantification as per 
ICH Guidelines [1]. For determining these parameters, it 
is significant to have pre-requisite knowledge of operating 
a UV-Visible Spectrophotometer, preparation of serial 
dilutions, calibration curve development and mathematical 
knowledge for determining mean, standard deviation (SD) 
and percent relative standard deviation (% R.S.D.).
In recent times, herbal drugs are gaining attention 
for treating various disorders other than the conventional 
synthetic drugs. One such herbal drug is the Ellagic 
Acid with IUPAC name 2,3,7,8-tetrahydroxy(1)
benzopyrano[5,4,3-cde][1]benzopyran-5,10-dione. It 
belongs to the class of polyphenols and is a dilactone of 
hexa-hydroxydiphenic acid [2] with structural formula 
C14H6O8 [3]. The pharmacokinetic parameters of ellagic 
acid are depicted in Figure 1. It is found in nuts (walnuts) 
and fruits like raspberries, strawberries, pomegranates, 
grapes and blueberries as ellagitannins [4]. It consists of 
4-OH groups and some lactone rings which together make 
its hydrophilic portion [4]. EA is poorly soluble in water 
(solubility ~9.7µg/ml) but is soluble in organic solvents like 
methanol (solubility is ~671µg/ml), N-methyl pyrolidone 
(NMP), Pyridine, Polyethylene glycol 400 (PEG 400), 
Triethanolamine (TEA) and in PEG 200 [2]. It is a multi-
functional drug and has anti-oxidant, anti-atherosclerotic, 
anti-inflammatory and anti-proliferative activities. EA 
can be used in the treatment of many diseases such as 
cardiovascular diseases, neurodegenerative disorders and 
various forms of cancers (cancer of breast, brain, prostate, 
lungs, etc. [4]. So, it is vital to validate the UV-Spectroscopic 
method of Ellagic acid.
The proposed UV method is important and novel as in 
previous studies UV method has not been validated using 
PEG200 as a solubilizing agent for EA. Avachat et al., 2015 
developed EA formulation as a complex of ellagic acid and 
phospholipid by dissolving ellagic acid in methanol and then 
determined the various parameters such as solubility, in-vitro 
dissolution studies, etc. through UV at wavelength 255nm 
[2]. Bala et al., 2006 had also validated the UV method for 
ellagic acid but the difference in his study and the current 
one is that they validated the method by dissolving ellagic 
acid in methanol and simultaneously preparing the dilutions 
of the standard solution in phosphate buffer pH 7.4 [5], 
while in the current procedure the drug is dissolved in 
PEG200 with subsequent dilutions of the standard solution 
with water. UV method for ellagic acid with PEG200 was 
developed as the already existing procedure with methanol as 
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methanol is comparatively costly, volatile and flammable in 
nature. In contrast, PEG200 is economical, biodegradable, 
non-volatile and has been certified as ‘safe’ for internal 
consumption by FDA [6]. Chen et al, 2006 developed UV 
method for EA quantification by taking NaOH as diluent, 
but in present study, the method was developed using 
PEG200 as a solubilizing agent followed by water as diluent 
[7]. Shah et al., 2017 also published the HPLC and HPTLC 
methods for estimation of ellagic acid in anti-diabetic 
formulations. This also prompted the study to be conducted 
using UV-Spectrophotometer as it is economical, easy and 
sensitive equipment, whereas HPLC is costly, complex and 
poorly sensitive for some herbal or nature origin compounds 
[3]. Briefly, this study aims at validating the UV analytical 
method for ellagic acid using PEG200 as a solvent of choice 
with λmax of 277nm.
2. Materials Used
Instruments: The UV Spectroscopy was executed on double 
beam SHIMADZU spectrophotometer (UV vis-1800) along 
with 2nm spectral bandwidth while using 10mm matched 
quartz cuvettes. For reference as well as test solutions, the 
absorption spectra were obtained in the range 200–400 nm 
(Figure 2A). Shimadzu digital (AX 200) balance was used 
for weighing. The bath sonicator (Life Care Equipments 
Pvt. Ltd, India) was utilized for ultrasonication mediated 
solubilization of ellagic acid in PEG200. 
Chemicals: The ellagic acid was obtained from HiMedia. 
All other chemicals were of high purity analytical grade 
and were used as received. A calibrated analytical balance 
was used for doing all the weighing. Calibrated glass wares 
were used throughout the study. Wherever water was to be 
utilized, double distilled water was used.
3. Experimental 
3.1. Method Development
3.1.1. Standard stock solution preparation
5 mg of drug was weighed and added to 10ml of PEG200 
with subsequent sonication of the mixture so as to obtain 
complete dissolution of the drug in the solvent. 5ml of drug 
solution was withdrawn from the prepared solution and was 
diluted with distilled water to obtain 50µg/ml concentration. 
Further dilutions were carried out with distilled water to 
obtain the concentration in the range of 1-5 µg/ml. 
3.1.2. Determination of  λmax for Ellagic acid
A scan was run in the UV-Visible Spectrophotometer taking 
5µg/ml concentration (diluted from stock solution) as the 
test sample (Figure 2A). The peak of maximum absorbance 
was obtained at 277nm for EA dissolved in PEG200. All 
the samples were hence analyzed at 277nm throughout the 
validation procedure.
3.1.3. Preparation of the calibration curve
From the stock solution, the samples with 1-5µg/ml 
concentrations range were prepared in triplicate and 
analyzed in the spectrophotometer at 277nm against 10% 
PEG200 solution in water as blank. Calibration curve was 
prepared as concentration v/s absorbance graph from the 
readings obtained in triplicate of each sample concentration 
(Figure 2B).
3.1.4. Correlation equation method
The concentration v/s absorbance graph was plotted in 
the GraphPad Prism 7 software. Trendline was formatted 
to obtain the intercept, slope, correlation coefficient and 
regression equation from the graph so obtained.
3.2. Validation of the method
3.2.1. Linearity
The value for correlation coefficient and regression equation 
can be procured via the calibration curve for the straight 
line obtained.
3.2.2. Precision 
To determine the precision, analysis of three different 
concentrations on a given day (intra-day) and on three 
different days (inter-day repeatability) was carried out. The 
resulting absorbance obtained was checked in terms of % 
RSD for determining the precision and repeatability of the 
analytical method as per ICH Guidelines [1].
3.2.3. Accuracy
Accuracy of the data was evaluated by recovery experiments 
using the standard addition method. This study was 
performed by spiking known amount of EA (80, 100 
and 120%) to the 5µg/ml concentration. The amounts 
of standard recovered were calculated in terms of mean 
recovery with the upper and lower limits of % R.S.D [5,8]. 
3.2.4. Robustness
To achieve robustness, three different concentrations were 
checked for their absorbance at three different wavelengths, 
i.e. 276nm, 277nm and 278nm in sixlet. After this, mean, 
SD and % R.S.D. were determined from the obtained data 
[9]. 
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3.2.5. Limit of Detection (LOD) and Limit of 
Quantification (LOQ)
LOD and LOQ were calculated according to the 3s/m 
and 10s/m criterions, respectively, where s is the standard 
deviation of the absorbance (n = 10) of the blank sample 
and m is the slope of the corresponding calibration curve 
[10].
4. Application of the Validated Method
4.1 Entrapment Efficiency Determination 
The validated UV method was utilized for the 
determination of entrapment efficiency of nanoparticles 
containing ellagic acid. Once the nanoparticle pallet has 
been collected after centrifugation of the nanosuspension, 
the supernatant of formulations was filtered through 
0.45 µm filter and their absorbance was measured for 
the amount of drug present in the supernatant using 
UV spectrophotometer. By applying the equation of 
the calibration curve as proposed by the GraphPad 
Prism 7.04 software, the corresponding concentrations 
were calculated. The amount of drug in supernatant 
(w) was then subtracted from the total amount of drug 
initially added during the preparation of nanoparticles. 
The percentage drug entrapment efficiency (DEE) was 
calculated using the formula [11]:
 
DEE




 amount of drug(W)
×100
4.2 In-vitro Drug Release 
The in vitro drug release from formulated nanoparticle 
batch was quantitatively estimated by using the calibration 
curve of validated UV method. Briefly, the drug-loaded 
nanoparticles (equivalent to specified amount of drug) were 
suspended in 5ml phosphate buffer saline (PBS, pH 7.4) 
and kept in the dialysis membrane bag (Himedia, MWCO, 
molecular mass cut off 12000–14000, pore size 2.4nm). The 
dialysis bag was kept in 200mL PBS (37±1°C; 50rpm). 5ml 
aliquots were collected and replaced with equal volume at 
regular time intervals. The collected aliquots were evaluated 
for the concentration of drug using the equation proposed 
by the GraphPad Prism 7.04 software [12].
5. Results and Discussion 
The proposed analytical method is simple, convenient, 
accurate, economical and rapid for determining the 
concentration of EA. A wavelength maximum was obtained 
at 277nm for EA. The calibration curve developed after 
analyzing the concentrations from 1-5µg/ml in triplicate in 
UV-Spectrophotometer gave correlation coefficient of 0.9994 
with regression equation y=0.04905x +0 and hence, slope 
value being 0.04905 and intercept being zero (Figure 1). The 
correlation coefficient value reflects that the spectroscopic 
procedure is in accordance with the Beer-Lambert’s Law. 
The precision and robustness of the analytical method was 
determined by calculating percent relative standard deviation 
(% R.S.D.) from the mean value indicating the accuracy of 
the procedure as per ICH Guidelines. % R.S.D. for intra-
day precision was found to be in the range 1-3% (Table 1) 
whereas for inter-day precision was between 2-3% (Table 1). 
The results suggest that the developed UV method is precise 
and provides recoverable data when analyzed on same day 
and also on different days but under similar environmental 
conditions. % R.S.D. for robustness was within 2-3.5% 
showing that the absorbance values deviated only less than 
3.5% when determined on three consecutive wavelengths 
one proceeding the maximum wavelength procured, second 
being the maximum wavelength itself and third succeeding 
the lambda maxima (i.e. 276nm, 277nm and 278nm 
respectively) (Table 1). After spiking the additional EA to 
5µg/ml solution, the range was found to vary from 94.47 % 
to 106.83 %, which depicts the accuracy of the developed 
UV method. 
Figure 1. Pharmacokinetic profile of Ellagic Acid
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LOD value of the developed method for the drug substance 
was found to be 0.04µg/ml and LOQ obtained was 
0.11µg/ml (Table 1). Thus, the developed method is 
sensitive and able to quantify the drug concentration in 
nano-gram levels.
Figure 2A. UV Sacn of Ellagic Acid 2B Calibration curve of 
Ellagic Acid at 277nm.
The %R.S.D. value was obtained below 4% and the correlation 
coefficient >0.99 (Table 1). This signify that the proposed 
UV-Spectroscopic method is valid and eligible for efficiently 
determining the concentrations of drug when present in an 
unknown amount, finding the drug entrapment efficiency, 
drug content, yield value, in-vitro dissolution studies of the 
drug formulation, thereby computing the cumulative drug 
release, quantification of the analyte in biological fluids, 
assessment of the drug even when present in very low dose, 
detecting amino acids, proteins, alkaloids, etc. So, it can be 
assumed that the method developed in current study can 
be extrapolated in future for determining the ellagic acid 
concentration in mouse and human plasma samples [12]. 
UV-Spectroscopy has also been recognized as a new 
Process Analytical Technology (PAT) for quantifying the 
active pharmaceutical ingredients when present in low dose 
in the form of gels and suspensions [13]. In their study, the 
UV method was compared to the already existing PAT tool 
RAMAN Spectroscopy for estimating the API present in 
semisolid (gel) and liquid (suspension) in small quantities 
[13]. The average percent drug entrapment efficiency of 
ellagic acid encapsulated chitosan nanoparticles was found 
to be 86.21±3.73% and the percentage drug release was 
found to be 43.60±1.70% after 24 hrs.





2. Correlation coefficient, r 0.9994
3. Regression equation y = 0.04905x + 0
4. R2 value 0.9988
5. Slope 0.04905
6. Intercept 0
7. Precision-Intra-day (%R.S.D.) 1%–3%
8. Precision-Inter-day (%R.S.D.) 2%–3%
9. Robustness (%R.S.D.) 2%–3.5%
10. LOD (µg/ml) 0.04
11. LOQ (µg/ml) 0.11
12. Accuracy 94.47 % –106.83 %
6. Conclusion
The anticipated UV spectrophotometric method is sensitive, 
quiet uncomplicated, in-destructive, fast, exact, rigid and 
cost efficient. In terms of linearity, accuracy, precision, 
specificity, robustness and reproducibility, the method 
is validated. The acceptable results so obtained imply 
that the method developed is successful in carrying out 
the studies requiring the use of UV-Spectroscopy for the 
determination of concentration and strengths of the drug 
in the test substance and also the quantitative assessment 
of biochemical compounds such as proteins, alkaloids, 
flavonoids, etc. 
Hence, it can be concluded that the proposed UV 
method is validated and therefore, can be used in future for 
productively estimating the concentrations of known and 
unknown compounds in various types of drug formulations 
such as ointments, suspensions, gels, tablets, capsules, etc. 
The method is even suitable for quantitative analysis of 
drug in novel drug delivery systems like microparticle and 
nanoparticle systems and also for determining the quality 
and purity of the samples under investigation.
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